Hemab Therapeutics Holdings, Inc.
COAGFigures shown here come from public SEC filings. Dates beside each section show the available history.
SEC filings supply these figures; updates after the dates shown are not included. No annual financial history is available for this company. The latest insider filing shown is dated Jun 17, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Hemab Therapeutics Holdings, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-05-04 · RA Capital Healthcare Fund LP: Larger than all 15 other insider purchases of Common Stock on file. SEC filing
- 2026-05-04 · RA Capital Healthcare Fund LP: Larger than 14 of the 15 other insider purchases of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-16 | RA Capital Healthcare Fund LP · 10% owner | Common Stock | P — Open market or private purchase | +61,523 | 24.98 | SEC filing |
| 2026-06-15 | RA Capital Healthcare Fund LP · 10% owner | Common Stock | P — Open market or private purchase | +6,146 | 24.89 | SEC filing |
| 2026-05-20 | RA Capital Healthcare Fund LP · 10% owner | Common Stock | P — Open market or private purchase | +996 | 24.94 | SEC filing |
| 2026-05-19 | RA Capital Healthcare Fund LP · 10% owner | Common Stock | P — Open market or private purchase | +3,802 | 24.97 | SEC filing |
| 2026-05-12 | RA Capital Healthcare Fund LP · 10% owner | Common Stock | P — Open market or private purchase | +6,387 | 24.90 | SEC filing |
| 2026-05-11 | RA Capital Healthcare Fund LP · 10% owner | Common Stock | P — Open market or private purchase | +14,149 | 24.47 | SEC filing |
| 2026-05-11 | RA Capital Healthcare Fund LP · 10% owner | Common Stock | P — Open market or private purchase | +25,720 | 25.00 | SEC filing |
| 2026-05-08 | RA Capital Healthcare Fund LP · 10% owner | Common Stock | P — Open market or private purchase | +1,483 | 24.98 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-04 | RA Capital Healthcare Fund LP · Director, 10% owner | Series B Preferred Stock | C — Conversion of derivative security | −42,341 | SEC filing |
| 2026-05-04 | RA Capital Healthcare Fund LP · Director, 10% owner | Common Stock | C — Conversion of derivative security | +3,607,846 | SEC filing |
| 2026-05-04 | MARAGANORE JOHN · Director | Series C Preferred Stock | C — Conversion of derivative security | −817 | SEC filing |
| 2026-05-04 | MARAGANORE JOHN · Director | Series B Preferred Stock | C — Conversion of derivative security | −817 | SEC filing |
| 2026-05-04 | RA Capital Healthcare Fund LP · Director, 10% owner | Series A Preferred Stock | C — Conversion of derivative security | −27,720 | SEC filing |
| 2026-05-04 | RA Capital Healthcare Fund LP · Director, 10% owner | Series C Preferred Stock | C — Conversion of derivative security | −10,054 | SEC filing |
| 2026-05-04 | Novo Holdings A/S · 10% owner | Common Stock | C — Conversion of derivative security | +4,180,550 | SEC filing |
| 2026-05-04 | Novo Holdings A/S · 10% owner | Series B Preferred Stock | C — Conversion of derivative security | −62,121 | SEC filing |
Showing 8 of 15 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.